PROTECT-Study

Multicenter, prospective, randomized study investigating the Efficacy and Safety of a low dosed Tacrolimus once daily regimen in comparison to standard Tacrolimus once daily exposure in stable renal transplant patients. Study purpose: To establish efficacy and safety (including renal function) of a reduced dose of once daily tacrolimus for patients with stable renal transplants EudraCT-No: 2013-000224-34